ScreenerHero

ADTX Aditxt, Inc.

NAS · US · Healthcare · Biotechnology · aditxt.com
0.0043USD-4.44%Mkt Cap: 4.29M $P/E: —

Aditxt, Inc. focuses on discovery and development of biopharmaceutical products. The company develops AditxtScore and FlowSpot that enable individuals to understand, manage, and monitor their immune profiles in order to …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap4.29M USD
Enterprise Value2.07M USD
Revenue (TTM)14.34K USD
Gross Profit268 USD
Net Income (TTM)-41.71M USD
Revenue/Share0.37 USD
Last Price0.0043 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees26
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.00
PEG—
EV/EBITDA-0.12
EV/Revenue144.39
P/S208.84
P/B-0.00
EPS (TTM)26271114.00
EPS (Forward)-11.29
52W Range
0.00200% of range27092.88
52W High27092.88 USD
52W Low0.0020 USD
Profitability
Gross Margin8.39%
Oper. Margin-35873.53%
EBITDA Margin0.00%
Profit Margin-1305608.79%
ROE-743.61%
ROA-252.56%
Growth
Revenue Growth1094.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-25.69M USD
CapEx (TTM)13.74K USD
FCF Margin-86119.09%
FCF Yield-287.70%
Net Debt3.96M USD
Net Debt/EBITDA-0.22
Balance Sheet
Debt/Equity0.54
Current Ratio0.06
Quick Ratio0.02
Book Value/Sh-861.43 USD
Cash/Share0.33 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:27
Split DateMay 18, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.997.98M
Float815.40K
Insiders0.41%
Institutions0.46%
Short Interest
Short Ratio0.0d
Short % Float34.50%
Short % Out.34.50%
Shares Short281.50K
Short (prev mo.)3.39K
Technical
SMA 500.0046 (-6.1%)
SMA 20052.68 (-100.0%)
Beta—
S&P 52W Chg16.45%
Avg Vol (30d)11.32M
Avg Vol (10d)11.92M
Technical Indicators
RSI (14)17.5
MACD-0.0341
MACD Signal-0.0500
MACD Hist.+0.0159
BB Upper0.0101 USD
BB Middle0.0058 USD
BB Lower0.0015 USD
BB Width148.03%
ATR (14)0.0105 USD
Vol Ratio (20d)0.62x